Juul Faces Market Withdrawal in the US: Implications and Controversies

Jul.08.2022
Juul Faces Market Withdrawal in the US: Implications and Controversies
The FDA ordered Juul products to be removed from the US market due to concerns over youth vaping.

On June 23, the US Food and Drug Administration (FDA) announced that all Juul products must be removed from the US market. This decision significantly expanded the existing ban on the company's nicotine e-cigarettes among teenagers to include adults as well. The following day, Juul appealed to the federal court to temporarily halt the ban and questioned the decision. The court agreed to temporarily suspend the ban, and currently, Juul products are still being sold in the US.


Lynn Kozlowski, a professor at the State University of New York at Buffalo's School of Public Health and Health Professions, has been researching nicotine and tobacco addiction for several decades. In this Q&A, he addresses the recent controversy surrounding Juul products and how they fit into broader discussions among adults and young people about e-cigarettes, tobacco use, and public health.


Why does the US Food and Drug Administration want to stop the sale of Juul products?


According to the FDA, the decision to remove certain flavored electronic cigarette products from the market is a preventative measure due to the lack of "sufficient evidence of product toxicology profiles" to ensure public health and safety. The FDA also noted that it has not received any information indicating that Juul products pose an imminent danger.


In a statement, FDA Commissioner Robert M. Califf addressed the impact of Juul products on youth e-cigarette use. This decision comes as some are hoping for new bans on Juul products and other adult e-cigarettes, in effort to decrease teen e-cigarette usage.


How do the health risks of electronic cigarettes compare to traditional smoking?


At least half of smokers die prematurely due to cancer, obstructive lung disease and cardiovascular diseases caused by smoking, which shorten their average lifespan by 10 years.


Currently, there is a lack of long-term epidemiological data on e-cigarettes. However, assessments conducted in the United States and the United Kingdom have concluded that while the harm from e-cigarettes may be much less than that of traditional cigarettes, they still pose some risks. Potential hazards include nicotine addiction and some cardiovascular risks, although it is estimated that these risks are lower than those associated with smoking cigarettes.


Can electronic cigarettes reduce the harm caused by traditional smoking?


I do not encourage anyone to vape if they do not need to. However, if someone smokes and e-cigarettes help them quit completely, they can be a useful tool in reducing smoking and health issues. Quitting smoking is indisputably good for your health. Research shows that if someone quits smoking before the age of 40, they can avoid 90% of their risk of death compared to continuing to smoke. If someone quits smoking before the age of 30, their health risks are almost the same as someone who has never smoked.


The Centers for Disease Control and Prevention states that there is limited evidence to suggest that e-cigarettes aid in smoking cessation. The U.S. Food and Drug Administration has approved some e-cigarettes for sale, noting that they can be a beneficial tool for smokers in significantly reducing their tobacco use or quitting altogether.


Recent research has shown that electronic cigarettes are more effective in aiding smokers to quit than nicotine replacement therapy. The UK National Health Service has approved electronic cigarettes as a recognized form of smoking cessation aid.


Is vaping still popular among teenagers as it was before?


Teen e-cigarette use is on the decline, according to data from the Centers for Disease Control and Prevention. In 2019, 27.5 percent of high school students reported having used e-cigarettes within the past month. That number dropped to 19.6 percent by 2020, and again to 11.3 percent by 2022. Just over a quarter of monthly users, or roughly 3 percent of high schoolers in 2022, reported using e-cigarettes daily.


Some of the reduction may be due to COVID-19, restrictions on young people's access, and government anti-vaping campaigns.


The widespread publicity around the serious respiratory illness caused by e-cigarettes, known as EVALI, is likely to deter many people from using them. However, research has ultimately shown that the illness is primarily caused by illicit THC-containing e-cigarette products sold on the black market.


Will teenagers who vape lead to a higher smoking rate among adolescents?


Although the decrease in teen e-cigarette use is encouraging, an important question worth asking is whether e-cigarettes directly lead to smoking later on.


Parents have valid reasons to be concerned that e-cigarettes may serve as a gateway to smoking. However, research does not necessarily support this strong causal relationship. Despite the recent surge in e-cigarette use across the country, smoking rates have actually decreased.


According to data from a national survey of nearly 40,000 participants in the US over the past few years, researchers have found that less than 1% of those who tried e-cigarettes for the first time became long-term smokers. Compared to those who first tried cigarettes or other tobacco products, people who first tried e-cigarettes were also less likely to become smokers.


Another large-scale study on American youth found that once researchers controlled for general risky behavior, the history of using e-cigarettes was only moderately or insignificantly associated with increased smoking rates.


How do you balance adult usage with teenage safety?


Even though e-cigarettes are not a major factor contributing to youth smoking, the use of e-cigarette products by young people is still a cause for concern, despite the ban on selling e-cigarettes to those under the age of 21 in 2019.


Completely banning products that may be helpful for adult smokers who want to quit is not the only way to reduce young people's access to these services. As an example, a proposal suggests moving the sales of all nicotine and tobacco products to stores that only allow entry for individuals of 21 years or older.


While products like Juul deserve research and regulation, it is important to remember the established deadline for verification and the ease of access for cigarettes - whether it is for adults or the many teenagers who start smoking every year and will become adult smokers. Persuading as many smokers to quit as possible will save lives.


This article contains excerpts or reprints from third-party sources, and the copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any unit or individual who needs to reprint must contact the author, and direct reprinting is prohibited.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | PMI Launches Three IQOS ILUMA i BEYOND Limited Editions in Japan, Retaining REMIX Pricing and Retail Channel Structure
Product | PMI Launches Three IQOS ILUMA i BEYOND Limited Editions in Japan, Retaining REMIX Pricing and Retail Channel Structure
Philip Morris Japan (PMJ) began launching three IQOS ILUMA i BEYOND limited-edition heated tobacco devices in Japan on November 18, 2026, covering PRIME, the standard ILUMA i and ONE. Suggested retail prices are ¥11,980, ¥7,980 and ¥4,980, respectively, matching the REMIX limited-edition collection introduced in June. BEYOND features blue finishes, translucent components and differentiated surface materials while retaining the existing IQOS ILUMA i device architecture. As with REMIX, all three models are available through official and specialist retail channels, while the subsequent convenience store rollout covers only the standard ILUMA i and ONE versions. The two collections share the same pricing tiers and retail distribution structure, with their principal differences in exterior design.
product
Nov.20
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma passed a government-sponsored amendment on November 11, 2026, by 414 votes to none, seeking to prevent businesses from classifying information on the presence and number of types of certain harmful ingredients in tobacco and nicotine-containing products as trade secrets. The measure covers ingredients capable of increasing nicotine dependence or exhibiting toxic, carcinogenic, mutagenic or reproductive toxicity, including substances that acquire such properties during heating or smoldering. Bill No. 1286415-8 would amend Article 5 of Federal Law No. 98-FZ on Commercial Secrets and is scheduled to take effect on January 1, 2027. The bill has cleared all three readings in the State Duma but has not completed the remaining legislative procedures.
Regulations
Nov.12 by 2Firsts Perspectives
Imperial Brands Plans to Cut Nearly 18% of Workforce as German Plant Closure and Polish Outsourcing Drive Restructuring
Imperial Brands Plans to Cut Nearly 18% of Workforce as German Plant Closure and Polish Outsourcing Drive Restructuring
Imperial Brands disclosed on November 17, 2026, that its global manufacturing and organisational restructuring is expected to reduce between 4,200 and 4,600 roles by the end of 2030, equivalent to approximately 16%–18% of its workforce at the end of 2025. The first phase covers 2,100 roles with departures confirmed or subject to consultation, while a further 2,100–2,500 positions are expected to be eliminated by 2030. The company is proceeding with the closure of its Langenhagen factory in Germany, has sold its manufacturing facility in Taiwan, and has transferred selected finance, procurement and supply-chain operations in Poland to Capgemini. The restructuring programme is expected to cost approximately £740 million, with Imperial targeting at least £320 million in annual cost savings by 2030.
company
Nov.18
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
Russia's Vape Ban Decisions Reach 17 Regions With 39 More Considering Laws, Putting Over 3,000 St. Petersburg Retail Outlets in Focus
Russia's Vape Ban Decisions Reach 17 Regions With 39 More Considering Laws, Putting Over 3,000 St. Petersburg Retail Outlets in Focus
Russia's regional vape retail restrictions are expanding. State Duma Speaker Vyacheslav Volodin said on November 7 that 17 regions had adopted decisions to ban vape sales, while another 39 were preparing or considering similar legislation. On November 12, lawmakers in Leningrad Oblast and the Republic of Karelia adopted bans scheduled to begin on March 1, 2027. A day earlier, St. Petersburg unanimously approved a five-year ban proposal in its first reading. The city has 615 specialist vape shops and more than 2,400 other retail outlets selling vaping products alongside other goods. Under Federal Law No. 186-FZ, enacted in June 2026, Russian regions may prohibit retail sales of electronic nicotine delivery systems and related liquids between March 2027 and March 2032. The legislation also restricts licensed suppliers from delivering covered products to retail premises in regions where bans apply.
Regulations
Nov.13